S. Gail Eckhardt
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 9
- Angiogenesis and VEGF in Cancer 3
- Oncology 19
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 4
- Co-authors
- Natalie J. Serkova (2 shared papers)Jennifer L. Spratlin (1 shared paper)Daniel D. Von Hoff (16 shared papers)Eric K. Rowinsky (17 shared papers)Geoffrey R. Weiss (8 shared papers)John R. Eckardt (8 shared papers)Lisa A. Hammond (9 shared papers)David Rinaldi (4 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Clinical Cancer Research (3 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
S. Gail Eckhardt
52 papers receiving 2.8k citations
S. Gail Eckhardt's Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 925
- Cancer Research 511
- Molecular Biology 1.6k
- Genetics 141
- Pulmonary and Respiratory Medicine 340
Countries citing papers authored by S. Gail Eckhardt
This map shows the geographic impact of S. Gail Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Gail Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Gail Eckhardt more than expected).
Fields of papers citing papers by S. Gail Eckhardt
This network shows the impact of papers produced by S. Gail Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Gail Eckhardt. The network helps show where S. Gail Eckhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Gail Eckhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Applications of Metabolomics in Oncology: A Review Hit paper breakdown → | 2009 | 590 |
| 2 | 2010 | 377 | |
| 3 | 1996 | 306 | |
| 4 | 1999 | 118 | |
| 5 | A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. | 2002 | 112 |
| 6 | 2009 | 100 | |
| 7 | 1994 | 94 | |
| 8 | A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies. | 2002 | 75 |
| 9 | 2000 | 73 | |
| 10 | 1999 | 69 | |
| 11 | 1998 | 67 | |
| 12 | 2017 | 63 | |
| 13 | A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies. | 1999 | 63 |
| 14 | 1999 | 62 | |
| 15 | Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model. | 1999 | 61 |
| 16 | 2004 | 54 | |
| 17 | 2004 | 47 | |
| 18 | A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide. | 1998 | 39 |
| 19 | 2000 | 37 | |
| 20 | 2002 | 37 |
About S. Gail Eckhardt
S. Gail Eckhardt is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 54 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Research Studies (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Oncology (925 citations), Cancer Research (511 citations), Molecular Biology (1.6k citations), Genetics (141 citations) and Pulmonary and Respiratory Medicine (340 citations). S. Gail Eckhardt has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Natalie J. Serkova, Jennifer L. Spratlin, Daniel D. Von Hoff, Eric K. Rowinsky, Geoffrey R. Weiss, John R. Eckardt, Lisa A. Hammond, David Rinaldi, Roy S. Herbst and John G. Kuhn. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, European Journal of Cancer, Annals of Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.